Eversept Partners, LP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 53 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$1,549,322
-25.7%
371,540
-7.5%
0.12%
-10.5%
Q4 2021$2,083,993
-20.1%
401,540
+0.9%
0.13%
-26.5%
Q3 2021$2,607,385
-17.0%
398,074
-15.9%
0.18%
-13.4%
Q2 2021$3,141,211
+126.7%
473,074
+205.2%
0.21%
+28.2%
Q4 2020$1,385,530
-66.5%
154,981
-40.0%
0.16%
-71.3%
Q2 2020$4,141,511
+229.2%
258,360
+23.0%
0.57%
+81.5%
Q1 2020$1,257,978210,0130.31%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$38,130,00036.42%
FRAZIER MANAGEMENT LLC 3,746,857$19,446,0001.50%
TFG Asset Management GP Ltd 2,700,000$14,013,0000.84%
Nantahala Capital Management 4,077,509$21,162,0000.74%
Ikarian Capital, LLC 544,819$2,827,0000.42%
HARBOR CAPITAL ADVISORS, INC. 211,319$1,097,0000.40%
Blackstone Inc. 17,985,611$93,345,0000.23%
Resolute Capital Asset Partners LLC 65,115$338,0000.22%
MYDA Advisors LLC 125,000$649,0000.17%
Eversept Partners, LP 401,540$2,083,9930.13%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders